Loading…

No definitive evidence for L-Zagreb mumps strain associated aseptic meningitis: a review with special reference to the da Cunha study

The study by da Cunha et al. published in 2002 reported that MMR vaccine containing L-Zagreb mumps strain manufactured by Serum Institute of India Ltd. caused a high incidence of aseptic meningitis (AM) from routine surveillance during two mass immunization campaigns (MIC) conducted in 1998 in two s...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2005-11, Vol.23 (46), p.5286-5288
Main Authors: Kulkarni, P.S., Phadke, M.A., Jadhav, S.S., Kapre, S.V.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c455t-e01e5bfcabfa4bb813b9d5937db7c0411e546c92b8591567e134475b07379c7f3
cites cdi_FETCH-LOGICAL-c455t-e01e5bfcabfa4bb813b9d5937db7c0411e546c92b8591567e134475b07379c7f3
container_end_page 5288
container_issue 46
container_start_page 5286
container_title Vaccine
container_volume 23
creator Kulkarni, P.S.
Phadke, M.A.
Jadhav, S.S.
Kapre, S.V.
description The study by da Cunha et al. published in 2002 reported that MMR vaccine containing L-Zagreb mumps strain manufactured by Serum Institute of India Ltd. caused a high incidence of aseptic meningitis (AM) from routine surveillance during two mass immunization campaigns (MIC) conducted in 1998 in two states in Brazil. Since the results were contrary to those in India, Egypt and Bahamas, a critical analysis of the study was done. Several inconsistencies were found in the study, which undermined the conclusions drawn. Two similar studies from Brazil reported similar results. Review of these studies and those done on the vaccine from Zagreb, Croatia showed that in no study the L-Zagreb mumps virus has been isolated from cerebrospinal fluid (CSF) of an AM case. Isolation of the vaccine virus is necessary for definite causal association of AM with the vaccine. There is no such evidence to causally link MMR vaccine containing L-Zagreb mumps strain with AM.
doi_str_mv 10.1016/j.vaccine.2005.05.029
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68802051</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X05005505</els_id><sourcerecordid>3420505501</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-e01e5bfcabfa4bb813b9d5937db7c0411e546c92b8591567e134475b07379c7f3</originalsourceid><addsrcrecordid>eNqFkduKFDEQhoMo7rj6CEpAEG96TLo7ncQbkcFVYdAbBfEm5FC9k2H6YNI9yz6A7231zoDghQsFCclXf0h9hDznbM0Zb97s10frfexhXTIm1kuV-gFZcSWrohRcPSQrVjZ1UXP244I8yXnPEKy4fkwuuNAKt2JFfn8ZaIA29nGKR6BwjAF6D7QdEt0WP-11Ake7uRszzVOysac258FHO0HALYxT9LSDPvbXmJDfUksThsANvYnTjuYRkD3gWQvpLnga6LQDGizdzP3OYuocbp-SR609ZHh2Xi_J96sP3zafiu3Xj58377eFr4WYCmAchGu9da2tnVO8cjoIXcngpGc1x9u68bp0SmguGgm8qmspHJOV1F621SV5dcod0_BrhjyZLmYPh4PtYZizaZRiJRP8XnCBdKMaBF__F-SCMam40gLRl_-g-2FOPf4XKaHQiCglUuJE-TTkjHMzY4qdTbeGM7OYN3tzNm8W82apUmPfi3P67DoIf7vOqhF4dwIAB4yGksk-LkpCTOAnE4Z4zxN_ACoEwhY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1558985527</pqid></control><display><type>article</type><title>No definitive evidence for L-Zagreb mumps strain associated aseptic meningitis: a review with special reference to the da Cunha study</title><source>ScienceDirect Journals</source><creator>Kulkarni, P.S. ; Phadke, M.A. ; Jadhav, S.S. ; Kapre, S.V.</creator><creatorcontrib>Kulkarni, P.S. ; Phadke, M.A. ; Jadhav, S.S. ; Kapre, S.V.</creatorcontrib><description>The study by da Cunha et al. published in 2002 reported that MMR vaccine containing L-Zagreb mumps strain manufactured by Serum Institute of India Ltd. caused a high incidence of aseptic meningitis (AM) from routine surveillance during two mass immunization campaigns (MIC) conducted in 1998 in two states in Brazil. Since the results were contrary to those in India, Egypt and Bahamas, a critical analysis of the study was done. Several inconsistencies were found in the study, which undermined the conclusions drawn. Two similar studies from Brazil reported similar results. Review of these studies and those done on the vaccine from Zagreb, Croatia showed that in no study the L-Zagreb mumps virus has been isolated from cerebrospinal fluid (CSF) of an AM case. Isolation of the vaccine virus is necessary for definite causal association of AM with the vaccine. There is no such evidence to causally link MMR vaccine containing L-Zagreb mumps strain with AM.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2005.05.029</identifier><identifier>PMID: 15985315</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Aseptic meningitis ; Autism ; Brazil - epidemiology ; Cerebrospinal fluid ; Child ; Children &amp; youth ; Drug Contamination ; Humans ; Immunization ; L-Zagreb mumps strain ; Mass Vaccination ; Meningitis, Aseptic - diagnosis ; Meningitis, Aseptic - etiology ; Meningitis, Aseptic - virology ; Mumps ; Mumps Vaccine - adverse effects ; Mumps virus ; Mumps virus - genetics ; Mumps virus - immunology ; Population Surveillance ; Vaccines ; Yugoslavia</subject><ispartof>Vaccine, 2005-11, Vol.23 (46), p.5286-5288</ispartof><rights>2005 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Nov 16, 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-e01e5bfcabfa4bb813b9d5937db7c0411e546c92b8591567e134475b07379c7f3</citedby><cites>FETCH-LOGICAL-c455t-e01e5bfcabfa4bb813b9d5937db7c0411e546c92b8591567e134475b07379c7f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15985315$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kulkarni, P.S.</creatorcontrib><creatorcontrib>Phadke, M.A.</creatorcontrib><creatorcontrib>Jadhav, S.S.</creatorcontrib><creatorcontrib>Kapre, S.V.</creatorcontrib><title>No definitive evidence for L-Zagreb mumps strain associated aseptic meningitis: a review with special reference to the da Cunha study</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>The study by da Cunha et al. published in 2002 reported that MMR vaccine containing L-Zagreb mumps strain manufactured by Serum Institute of India Ltd. caused a high incidence of aseptic meningitis (AM) from routine surveillance during two mass immunization campaigns (MIC) conducted in 1998 in two states in Brazil. Since the results were contrary to those in India, Egypt and Bahamas, a critical analysis of the study was done. Several inconsistencies were found in the study, which undermined the conclusions drawn. Two similar studies from Brazil reported similar results. Review of these studies and those done on the vaccine from Zagreb, Croatia showed that in no study the L-Zagreb mumps virus has been isolated from cerebrospinal fluid (CSF) of an AM case. Isolation of the vaccine virus is necessary for definite causal association of AM with the vaccine. There is no such evidence to causally link MMR vaccine containing L-Zagreb mumps strain with AM.</description><subject>Aseptic meningitis</subject><subject>Autism</subject><subject>Brazil - epidemiology</subject><subject>Cerebrospinal fluid</subject><subject>Child</subject><subject>Children &amp; youth</subject><subject>Drug Contamination</subject><subject>Humans</subject><subject>Immunization</subject><subject>L-Zagreb mumps strain</subject><subject>Mass Vaccination</subject><subject>Meningitis, Aseptic - diagnosis</subject><subject>Meningitis, Aseptic - etiology</subject><subject>Meningitis, Aseptic - virology</subject><subject>Mumps</subject><subject>Mumps Vaccine - adverse effects</subject><subject>Mumps virus</subject><subject>Mumps virus - genetics</subject><subject>Mumps virus - immunology</subject><subject>Population Surveillance</subject><subject>Vaccines</subject><subject>Yugoslavia</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqFkduKFDEQhoMo7rj6CEpAEG96TLo7ncQbkcFVYdAbBfEm5FC9k2H6YNI9yz6A7231zoDghQsFCclXf0h9hDznbM0Zb97s10frfexhXTIm1kuV-gFZcSWrohRcPSQrVjZ1UXP244I8yXnPEKy4fkwuuNAKt2JFfn8ZaIA29nGKR6BwjAF6D7QdEt0WP-11Ake7uRszzVOysac258FHO0HALYxT9LSDPvbXmJDfUksThsANvYnTjuYRkD3gWQvpLnga6LQDGizdzP3OYuocbp-SR609ZHh2Xi_J96sP3zafiu3Xj58377eFr4WYCmAchGu9da2tnVO8cjoIXcngpGc1x9u68bp0SmguGgm8qmspHJOV1F621SV5dcod0_BrhjyZLmYPh4PtYZizaZRiJRP8XnCBdKMaBF__F-SCMam40gLRl_-g-2FOPf4XKaHQiCglUuJE-TTkjHMzY4qdTbeGM7OYN3tzNm8W82apUmPfi3P67DoIf7vOqhF4dwIAB4yGksk-LkpCTOAnE4Z4zxN_ACoEwhY</recordid><startdate>20051116</startdate><enddate>20051116</enddate><creator>Kulkarni, P.S.</creator><creator>Phadke, M.A.</creator><creator>Jadhav, S.S.</creator><creator>Kapre, S.V.</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20051116</creationdate><title>No definitive evidence for L-Zagreb mumps strain associated aseptic meningitis: a review with special reference to the da Cunha study</title><author>Kulkarni, P.S. ; Phadke, M.A. ; Jadhav, S.S. ; Kapre, S.V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-e01e5bfcabfa4bb813b9d5937db7c0411e546c92b8591567e134475b07379c7f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Aseptic meningitis</topic><topic>Autism</topic><topic>Brazil - epidemiology</topic><topic>Cerebrospinal fluid</topic><topic>Child</topic><topic>Children &amp; youth</topic><topic>Drug Contamination</topic><topic>Humans</topic><topic>Immunization</topic><topic>L-Zagreb mumps strain</topic><topic>Mass Vaccination</topic><topic>Meningitis, Aseptic - diagnosis</topic><topic>Meningitis, Aseptic - etiology</topic><topic>Meningitis, Aseptic - virology</topic><topic>Mumps</topic><topic>Mumps Vaccine - adverse effects</topic><topic>Mumps virus</topic><topic>Mumps virus - genetics</topic><topic>Mumps virus - immunology</topic><topic>Population Surveillance</topic><topic>Vaccines</topic><topic>Yugoslavia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kulkarni, P.S.</creatorcontrib><creatorcontrib>Phadke, M.A.</creatorcontrib><creatorcontrib>Jadhav, S.S.</creatorcontrib><creatorcontrib>Kapre, S.V.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database (ProQuest)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Family Health</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Health Management</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kulkarni, P.S.</au><au>Phadke, M.A.</au><au>Jadhav, S.S.</au><au>Kapre, S.V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>No definitive evidence for L-Zagreb mumps strain associated aseptic meningitis: a review with special reference to the da Cunha study</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2005-11-16</date><risdate>2005</risdate><volume>23</volume><issue>46</issue><spage>5286</spage><epage>5288</epage><pages>5286-5288</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>The study by da Cunha et al. published in 2002 reported that MMR vaccine containing L-Zagreb mumps strain manufactured by Serum Institute of India Ltd. caused a high incidence of aseptic meningitis (AM) from routine surveillance during two mass immunization campaigns (MIC) conducted in 1998 in two states in Brazil. Since the results were contrary to those in India, Egypt and Bahamas, a critical analysis of the study was done. Several inconsistencies were found in the study, which undermined the conclusions drawn. Two similar studies from Brazil reported similar results. Review of these studies and those done on the vaccine from Zagreb, Croatia showed that in no study the L-Zagreb mumps virus has been isolated from cerebrospinal fluid (CSF) of an AM case. Isolation of the vaccine virus is necessary for definite causal association of AM with the vaccine. There is no such evidence to causally link MMR vaccine containing L-Zagreb mumps strain with AM.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>15985315</pmid><doi>10.1016/j.vaccine.2005.05.029</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2005-11, Vol.23 (46), p.5286-5288
issn 0264-410X
1873-2518
language eng
recordid cdi_proquest_miscellaneous_68802051
source ScienceDirect Journals
subjects Aseptic meningitis
Autism
Brazil - epidemiology
Cerebrospinal fluid
Child
Children & youth
Drug Contamination
Humans
Immunization
L-Zagreb mumps strain
Mass Vaccination
Meningitis, Aseptic - diagnosis
Meningitis, Aseptic - etiology
Meningitis, Aseptic - virology
Mumps
Mumps Vaccine - adverse effects
Mumps virus
Mumps virus - genetics
Mumps virus - immunology
Population Surveillance
Vaccines
Yugoslavia
title No definitive evidence for L-Zagreb mumps strain associated aseptic meningitis: a review with special reference to the da Cunha study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T10%3A16%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=No%20definitive%20evidence%20for%20L-Zagreb%20mumps%20strain%20associated%20aseptic%20meningitis:%20a%20review%20with%20special%20reference%20to%20the%20da%20Cunha%20study&rft.jtitle=Vaccine&rft.au=Kulkarni,%20P.S.&rft.date=2005-11-16&rft.volume=23&rft.issue=46&rft.spage=5286&rft.epage=5288&rft.pages=5286-5288&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2005.05.029&rft_dat=%3Cproquest_cross%3E3420505501%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-e01e5bfcabfa4bb813b9d5937db7c0411e546c92b8591567e134475b07379c7f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1558985527&rft_id=info:pmid/15985315&rfr_iscdi=true